Hypoxia-Inducible Factors and Kidney Vascular Development

Journal of the American Society of Nephrology

Volumn 14, Issue 11, 2003, Pages 2723-2730

  Freeburg, Paul B ^a   Abrahamson, Dale R ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; MITOGENIC AGENT; VASCULOTROPIN;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; ENDOTHELIUM CELL; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GLOMERULUS; HYPOXIA INDUCIBLE FACTOR GENE; KIDNEY BLOOD VESSEL; KIDNEY DEVELOPMENT; MICROVASCULATURE; MITOSIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION;

EID: 0142182766     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000092794.37534.01     Document Type: Review

References (76)

1. Rossant J, Howard L: Signaling pathways in vascular development. Annu Rev Cell Dev Biol 18: 541-573, 2002
2. Maxwell PH, Ratcliffe PJ: Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13: 29-37, 2002
3. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara, N: VEGF is required for growth and survival in neonatal mice. Development 126: 1149-1159, 1999
4. Abedi H, Zachary I: Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272: 15442-15451, 1997
5. Gerber HP, Dixit V, Ferrara N: Vascular endothelial growth factor induces expression of the anti-apoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273: 13313-13316, 1998
6. Richard DE, Berra E, Pouyssegur J: Nonhypoxic pathway mediates the induction of hypoxia-inducible factor la in vascular smooth muscle cells. J Biol Chem 275: 26765-26771, 2000
7. Gu YZ, Hogenesch JB, Bradfield CA: The PAS superfamily: Sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40: 519-561, 2000
8. Semenza GL, Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12: 5447-5454, 1992
9. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE: Hypoxiainducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci U S A 88: 5680-5684, 1991
10. Wang GL, Semenza GL: Purification and characterization of HIF-1. J Biol Chem 270: 1230-1237, 1995
11. Hoffman EC, Reyes H, Chuff EJ, Sander F, Conley LH: Cloning of a factor required for activation of the Ah (dioxin) receptor. Science 252: 954-958, 1991
12. Flamme I, Frohlich T, von Reutern M, Kappel A, Damert A, Risau W: HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor la and developmentally expressed in blood vessels. Mech Dev 63: 51-60, 1997
13. Gu YZ, Moran SM, Hogenesch JB, Wartman L, Bradfield CA: Molecular characterization and chromosomal localization of a third a-class hypoxia inducible factor subunit, HIF-3α. Gene Exp 7: 205-213, 1998
14. Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K, Poellinger L, Fuji-Kuriyama Y: Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300. EMBO J 18: 1905-1914, 1999
15. Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL: Transactivation and inhibitory domains of hypoxia-inducible factor-1α: Modulation of transcriptional activity by oxygen tension. J Biol Chem 272: 19253-19260, 1997
16. O'Rourke JF, Tian YM, Ratcliffe PJ, Pugh CW: Oxygen-regulated and transactivating domains of endothelial PAS protein 1: Comparison with HIF-1α. J Biol Chem 274: 2060-2071, 1999
17. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ: Activation of hypoxia-inducible factor-1; definition of regulatory domains within the α subunit. J Biol Chem 272: 11205-11214, 1997
18. Hara S, Hamada J, Kobayashi C, Kondo Y, Imura N: Expression and characterization of hypoxia-inducible factor (HIF)-3α in human kidney: Suppression of HIF-mediated gene expression by HIF-3α. Biochem Biophys Res Commun 287: 808-813, 2001
19. Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, Cao Y, Berkenstam A, Poellinger L: Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414: 550-554, 2001
20. Jiang BH, Rue E, Wang GL, Semenza GL: Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271: 17771-17778, 1996
21. Jiang BH, Semenza GL, Bauer C, Marti HH: HIF-1 levels vary exponentially over a physiologically relevant range of oxygen tension. Am J Physiol 271: C1172-C1180, 1996
22. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 95: 7987-7992, 1998
23. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Tanaka H, Poellinger L: Regulation of the hypoxia-inducible transcription factor la by the ubiquitin-proteasome pathway. J Biol Chem 274: 6519-6525, 1999
24. Salceda S, Caro J: Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272: 22642-22647, 1997
25. Wang GL, Jiang BH, Rue EA, Semenza GL: Hypoxia inducible factor 1 is a basic helix-loop-helix-PAS heterodimer regulated by cellular 02 tension. Proc Natl Acad Sci U S A 92: 5510-5514, 1995
26. 2, and the 3 PHDs: How animal cells signal hypoxia to the nucleus. Cell 107: 1-3, 2001
27. Tanimoto K, Makino Y, Periera T, Poellinger L: Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19: 4298-309, 2000
28. 2 sensing. Science 292: 464-468, 2001
29. 2-regulated prolyl hydroxylation. Science 292: 468-472, 2001
30. Maxwell P: HIF-1: An oxygen response system with special relevance to the kidney. J Am Soc Nephrol 14: 000-000, 2003
31. Kaelin WG: The von Hippel-Linau gene, kidney cancer, and oxygen sensing. J Am Soc Nephrol 14: 000-000, 2003
32. Agani F, Semenza GL: Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor-1 activity. Mol Pharm 59: 774-754, 1998
33. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J: p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1 alpha (HIF-1 alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274: 32631-32617, 1999
34. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL: Reciprocal positive regulation of hypoxia-inducible factor la and insulin-like growth factor 2. Cancer Res 59: 3915-3918, 1999
35. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E, Keshet E: Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation, and tumor angiogenesis. Nature 394: 485-490, 1998
36. Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashimoto K, D'Acquisto F, Makuuchi M, Esumi H: Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 276: 2292-2298, 2001
37. Gerber HP, Condorelli F, Park J, Ferrara N: Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes: Flt-1, but not Flk-/KDR, is upregulated in hypoxia. J Biol Chem 272: 23659-23667, 1997
38. Kappel A, Ronicke V, Damert A, Flamme I, Risau W, Breir G: Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood 93: 4284-4292, 1999
39. Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S, Acker T, Rauter M, Plate K, Sieweke M, Breier G, Flamme I: Cooperative interaction of hypoxia-inducible factor-2α (HIF-2α) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 278: 7520-7530, 2003
40. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles for the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74, 1995
41. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejeuski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60, 1997
42. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Hinda Y: Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274: 15732-15739, 1999
43. Semenza GL: HIF-1: Using two hands to flip the angiogenic switch. Cancer Metastasis Rev 19: 59-65, 2000
44. Pugh CW, Ratcliffe PJ: The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin Cancer Biol 13: 83-89, 2003
45. Levy AP, Levy NS, Wegner S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270: 13333-13340, 1995
46. Lee YM, Jeong CH, Koo SY, Son MJ, Song HS, Bae SK, Raleigh JA, Chung HY, Yoo MA, Kim KW: Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development. Dev Dyn 220: 175-186, 2001
47. Ryan HE, Lo J, Johnson RS: HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 17: 3003-3015, 1998
48. Ferrara N: Role of VEGF in regulation of physiological angiogenesis. Am J Physiol 280: C1358-C1366, 2001
49. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL: The hypoxia-responsive transcription factor EPASI is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12: 3320-3324, 1998
50. Peng J, Zhang L, Drysdale L, Fong GH: The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc Natl Acad Sci U S A 97: 8386-8391, 2000
51. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC: Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386: 403-407, 1997
52. Adelman DM, Maltepe E, Simon MC: Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev 13: 2478-2483, 1999
53. Keith B, Adelman DM, Simon MC: Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt 2) gene reveals partial redundancy with Arnt. Proc Natl Acad Sci U S A 98: 6692-6697, 2001
54. Drutel G, Kathmann M, Heron A, Schwartz JC, Arrang JM: Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator (ARNT). Biochem Biophys Res Commun 225: 333-339, 1996
55. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK: Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111: 1-6, 1998
56. Larcher F, Murillas R, Bolontrade M, Conti CJ, Jorcano JL: VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 17: 303-311, 1998
57. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM: Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514, 1999
58. Elson DA, Thurston G, Huang LE, Ginzinger DG, McDonald DM, Johnson RS, Arbeit JM: Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1 alpha. Genes Dev 15: 2521-2532, 2001
59. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P: Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702-710, 2002
60. Seagroves TN, Hadsell D, McManaman J, Palmer C, Liao D, McNulty W, Welm B, Wagner KU, Neville M, Johnson RS: HIF1 alpha is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development 130: 1713-1724, 2003
61. Bard J: The metanephros. In: The Kidney. From Normal Development to Congenital Disease (edited by Vise PD, Woolf AS, Bard JBL), London, Academic Press, 2003, pp 139-148
62. Kitamoto Y, Tokunaga H, Tomita K: Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J Clin Invest 99: 2351-2357, 1997
63. Abrahamson DR, Wang R: Development of the glomerular capillary and its basement membrane. In: The Kidney. From Normal Development to Congenital Disease (edited by Vise PD, Woolf AS, Bard JBL), London, Academic Press, 2003, pp 221-249
64. Daniel TO, Abrahamson D: Endothelial signal integration in vascular assembly. Annu Rev Physiol 62: 649-671, 2000
65. Robert B, Abrahamson DR: Control of glomerular capillary development by growth factor/receptor kinases. Pediatr Nephrol 16:294-301, 2001
66. Woolf AS, Yuan HT: Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development. Pediatr Nephrol 16: 177-184, 2001
67. Ulleras E, Wilcock A, Miller SJ, Franklin GC: The sequential activation and repression of the human PDGF-B gene during chronic hypoxia reveals antagonistic roles for the depletion of oxygen and glucose. Growth Factors 19: 233-245, 2001
68. Riconco JM, Xu Y, Arar M, Jin D, Barnes JL, Abboud HE: Morphological insights into the origin of glomerular endothelial and mesangial cells and their precursors. J Histochem Cytochem 51: 141-150, 2003
69. Alpers CE, Seifert RA, Hedkins KL, Johnson RJ, Bowenpope DR: Developmental patterns of PDGF-B chain, PDGF-receptor, and actin expression in human glomerulogenesis. Kidney Int 42: 390-399, 1992
70. Soriano P: Abnormal kidney development and hematological disorders in platelet-derived growth factor receptor knock out mice. Genes Dev 8: 1888-1896, 1994
71. Leveen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8: 1875-1887, 1994
72. Freeburg PB, Robert B, St John PL, Abrahamson DR: Podocyte expression of hypoxia-inducible factor (HIF)-1 and HIF-2 during glomerular development. J Am Soc Nephrol 14: 927-938, 2003
73. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DAH, Bauer C, Gassmann M, Candinas D: HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15: 2445-2453, 2001
74. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze C, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, Eckardt K: Widespread, hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs. FASEB J 17: 271-273, 2003
75. Eickelberg O, Seebach F, Riordan M, Thulin G, Mann A, Reidy KH, Van Why SK, Kashgarian M, Siegel N: functional activation of heat shock factor and hypoxia-inducible factor in the kidney. J Am Soc Nephrol 13: 2094-2101, 2002
76. Rosenberger C, Mandriota S, Jurgenses JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU: Expression of hypoxia-inducible factor-1 alpha and -2 alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13:1974-1976, 2002